Marksans Pharma reports Q1 FY26 financial results

Marksans Pharma reports Q1 FY26 financial results. The company has submitted unaudited financial results for the quarter ended June 30, 2026. This release follows the board meeting and provides key performance metrics for the first quarter. Further details on revenue, profit, and guidance will be analyzed upon full disclosure.

📊 STOCKS: MARKSANS | 🏢 SECTOR: Pharma | #Earnings #Pharma #Q1